Crunching the numbers. Responsibly.
BACKGROUND AND AIMS: The transcription factor Nrf2 is a major modulator of the cellular antioxidant response. Oxidative burst of infiltrating macrophages leads to a massive production of reactive oxygen species in inflamed tissue of inflammatory bowel disease patients. This oxidative burst contributes to tissue destruction and epithelial permeability, but it is also an essential part of the antibacterial defence. We therefore investigated the impact of the Nrf2 orchestrated antioxidant response in both acute and chronic intestinal inflammation. METHODS: To study the role of Nrf2 overexpression in mucosal inflammation, we used transgenic mice conditionally expressing a constitutively active form of Nrf2 [caNrf2] either in epithelial cells or in the myeloid cell lineage. Acute colitis was induced by dextran sulphate sodium [DSS] in transgenic and control animals, and changes in gene expression were evaluated by genome-wide expression studies. Long-term effects of Nrf2 activation were studied in mice with an IL-10-/- background. RESULTS: Expression of caNrf2 either in epithelial cells or myeloid cells resulted in aggravation of DSS-induced acute colitis. Aggravation of inflammation by caNrf2 was not observed in the IL-10-/- model of spontaneous chronic colitis, where even a trend towards reduced prolapse rate was observed. CONCLUSIONS: Our findings show that a well-balanced redox homeostasis is as important in epithelial cells as in myeloid cells during induction of colitis. Aggravation of acute DSS colitis in response to constitutive Nrf2 expression emphasises the importance of tight regulation of Nrf2 during the onset of intestinal inflammation.
Expression of caNrf2 either in epithelial cells or myeloid cells resulted in aggravation of DSS-induced acute colitis.
two cell-specific models showed concordant worsening across complementary acute-colitis outcomes
Aggravation of inflammation by caNrf2 was not observed in the IL-10-/- model of spontaneous chronic colitis, where even a trend towards reduced prolapse rate was observed.
the chronic design relies on underpowered null comparisons and non-significant sex-stratified trends
Our findings show that a well balanced redox homeostasis is equally important in epithelial cells as well as myeloid cells during induction of colitis.
parallel acute phenotypes support the interpretation, although the redox mechanism remains unresolved
Aggravation of acute DSS colitis in response to constitutive Nrf2 expression emphasizes the importance of tight regulation of Nrf2 during the onset of intestinal inflammation.
acute aggravation is consistent, but the experiment does not directly identify the optimal regulatory range
Derived from the full evaluation — not a separate score.
Strengths
Constitutive Nrf2 activation increased acute DSS disease severity in both epithelial and myeloid models, with significant effects across complementary outcomes such as weight loss, colon length, and histology.
↳ Results, Figures 1–2
The study reports significant, null, and trend-level outcomes, including unchanged colonoscopy and MPO measurements rather than presenting only supportive endpoints. Endoscopic scoring was performed by a blinded independent investigator.
↳ Materials and Methods; Results, Figures 1–2
The Discussion addresses Nrf2 knockout studies, sulforaphane and gallic-acid experiments, and divergent tissue-specific gain-of-function findings. It also distinguishes intermittent pharmacological activation from constitutive genetic activation.
↳ Discussion, pp. 21–23
Limitations
Numerous cytokine and gene-expression comparisons are reported across genotypes, treatments, lineages, and sexes without a stated multiplicity correction outside the RNA-sequencing analysis. This raises false-positive risk, particularly for Figure 7.
↳ Statistical Analysis; Results, Figures 3 and 7
The chronic model relies heavily on non-significant prolapse trends and sex-stratified analyses with n=4–8 for cytokine measurements. These data do not establish the acute-versus-chronic distinction with the same certainty as the acute findings.
↳ Results, Figures 5–7
The proposed distinction between remission maintenance and acute-flare therapy extrapolates from constitutive genetic activation in mice to pharmacological treatment in patients. The article itself notes that transient drug activation may behave differently.
↳ Discussion, pp. 21–26
The strongest evidence comes from Figures 1 and 2, where two cell-specific transgenic models show concordant worsening of acute DSS colitis across complementary outcomes. The methods are competent and null endpoints are reported transparently, but multiplicity and small secondary-analysis samples constrain mechanistic certainty. Figures 5–7 provide a useful chronic comparison, although underpowered null findings and sex-stratified trends cannot establish stage dependence as firmly as the acute experiments. The Discussion is well situated in contradictory Nrf2 literature, but its therapeutic timing proposal remains several translational steps beyond the intervention tested.
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
Sound3.5
The study meaningfully extends prior loss-of-function work by showing that constitutive Nrf2 activation aggravates acute DSS colitis in two cell lineages. The acute-versus-chronic contrast is informative, although the chronic evidence is largely null or trend-level.
Expression of caNrf2 either in epithelial cells or myeloid cells resulted in aggravation of DSS-induced acute colitis.
Two cell-specific transgenic systems, littermate controls, repeated acute experiments, multiple outcomes, and blinded endoscopy provide a competent design. Small chronic and RNA-sequencing samples, incomplete blinding, and uncorrected multiplicity in secondary analyses limit certainty.
Results represent two independent acute colitis experiments with a total of n = 14 per group.
The paper progresses coherently from the acute models to the chronic model and mechanistic follow-up, while distinguishing significant findings from trends. Translational language remains hedged, although several non-significant trends receive notable narrative weight.
where even a trend towards reduced prolapse rate was observed
The Discussion directly engages knockout, pharmacological-activation, and tissue-specific gain-of-function evidence and explains why constitutive activation may differ. Power limitations in the sex-stratified chronic analyses are not traced through the corresponding sex-specific interpretations.
This lower expression of pro-inflammatory cytokines corresponds well to the observed amelioration of colitis
No concerns4 of 4 checks
The numerical findings, methods, and central conclusions are internally coherent, and null outcomes are reported alongside significant results. A single IL-20 reference in the chronic-colitis section is an evident typographical error for IL-10.
Animal ethics authorization is declared and the RNA-sequencing data are assigned a GEO accession. No conflict-of-interest disclosure is visible in the supplied manuscript, but this is treated as an assessability gap rather than a conduct concern.
Flags: 2 declared / 5 total
70 of 70 checkable references verified
70 references in manuscript
No retraction notice found in Retraction Watch.
Sources: Retraction Watch ✓
Low2.5
The work addresses IBD treatment and proposes a general distinction between remission maintenance and acute-flare treatment. It does not identify a specific developer, clinical program, or actionable decision context.
Potential Nrf2 targeted therapies for IBD patients thus may be more beneficial for maintenance of remission
The evidence establishes a controlled murine mechanism rather than a therapeutic intervention. Constitutive genetic activation differs materially from the transient pharmacological activation discussed as the prospective application.
the activiation of Nrf2 by sulforaphane is transient in contrary to a genetic activation
The acute result appears in both epithelial and myeloid models, but the direction differs in the chronic model and sex-stratified chronic analyses are small. Transfer to pharmacological activation or human IBD is therefore uncertain.
These findings suggest different roles of Nrf2 activation during acute and chronic mucosal injury.
The study contributes directly to an active debate created by knockout studies and pharmacological Nrf2 activators. Its context-dependent gain-of-function evidence is suitable for further mechanistic and preclinical investigation.
Our results are in contrast to the common notion that Nrf2 activation is beneficial during colitis induction
AI-generated, human-governed. Something look off? Contact us to request a review.